MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 180 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,123,000 | -59.0% | 69,800 | -65.0% | 0.01% | -44.4% |
Q1 2022 | $5,175,000 | -38.5% | 199,341 | -51.6% | 0.01% | -40.0% |
Q4 2021 | $8,410,000 | +13.1% | 412,278 | +6.7% | 0.02% | +15.4% |
Q3 2021 | $7,434,000 | -16.2% | 386,428 | -3.4% | 0.01% | -13.3% |
Q2 2021 | $8,868,000 | -16.6% | 399,828 | -1.3% | 0.02% | -16.7% |
Q1 2021 | $10,637,000 | +94.1% | 405,228 | +38.2% | 0.02% | +80.0% |
Q4 2020 | $5,481,000 | +1823.2% | 293,300 | +1645.8% | 0.01% | +900.0% |
Q3 2020 | $285,000 | -73.4% | 16,800 | -84.7% | 0.00% | -50.0% |
Q4 2019 | $1,072,000 | +2.9% | 109,800 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $1,042,000 | -10.7% | 109,800 | +11.7% | 0.00% | 0.0% |
Q2 2019 | $1,167,000 | -32.6% | 98,300 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $1,731,000 | -21.3% | 98,300 | -22.4% | 0.00% | -25.0% |
Q4 2018 | $2,199,000 | -1.7% | 126,700 | -15.6% | 0.00% | +33.3% |
Q3 2018 | $2,237,000 | -14.3% | 150,200 | -8.5% | 0.00% | -25.0% |
Q2 2018 | $2,609,000 | +12.0% | 164,100 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,330,000 | – | 164,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |